跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 418 条关于
“Wilson Elser”
全部
418
临床试验
213
药物
11
机构
35
资讯
159
去年
Eton Pharmaceuticals Launches FDA-Approved Galzin for Wilson Disease Maintenance Treatment
去年
Monopar's ALXN1840 Shows Sustained Neurological Benefits in Long-Term Wilson Disease Study
10天前
Orphalan Initiates Global Phase 3 TRADITiONAL Study of Once-Daily Trientine in Wilson Disease
去年
ALXN1840 Shows Promising Long-Term Efficacy and Safety for Wilson Disease at EASL 2025
6个月前
Monopar Therapeutics Strengthens Leadership Team Ahead of ALXN1840 NDA Submission for Wilson Disease
7个月前
Avacta Therapeutics Promotes Francis Wilson to Chief Scientific Officer to Lead pre|CISION Platform Development
去年
Orphalan Makes History as First European Company to Enter China's Wilson Disease Market with "Ke Pei Ou"
去年
Monopar Therapeutics Advances Wilson Disease and Radiopharmaceutical Programs
7个月前
Wilson Disease Pipeline Shows Promise with ALXN1840 Completing Phase III Trial and Five Companies Advancing Novel Therapies
2年前
Gene Therapy Pioneer Jim Wilson Departs UPenn to Launch Two New Companies
第 1 页,共 16 页
上一页
下一页